Literature DB >> 23188446

The role of immunohistochemistry in the diagnosis of neoplastic pleural effusions.

Mihaela Dinu1, Raluca Niculina Ciurea, Mirela Stefan, Ana Claudia Georgescu.   

Abstract

Identification of the origin of neoplastic pleural effusion is a major concern in lung pathology. This study followed the diagnostic role of a panel of antibodies that included calretinin, HBME1, D2-40, Ber-EP4, CK5/6, CEA and TTF1, in a total of 37 cases of pleural and lung cancer with tumor-type cytology, later confirmed by histopathology. For mesothelioma, positive staining for calretinin, D2-40 and CK5/6 and negative for CEA and TTF1 were characteristic. For lung adenocarcinomas, we found Ber-EP4, CEA and TTF1 positivity, and calretinin, D2-40 and CK5/6 negativity. Squamous lung carcinomas were positive for Ber-EP4, CK5/6 and CEA and negative for HBME1, D2-40 and TTF1. The panel of antibodies used in this study provides a differential diagnosis between mesotheliomas and lung carcinomas as well as between lung adenocarcinomas and squamous carcinomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23188446

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  5 in total

Review 1.  Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.

Authors:  Elisa Barone; Federica Gemignani; Stefano Landi
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

2.  Diagnostic value of thyroid transcription factor-1 for pleural or other serous metastases of pulmonary adenocarcinoma: a meta-analysis.

Authors:  Yongchun Shen; Caishuang Pang; Konglong Shen; Yanqiu Wu; Diandian Li; Chun Wan; Zenglin Liao; Ting Yang; Lei Chen; Fuqiang Wen
Journal:  Sci Rep       Date:  2016-01-25       Impact factor: 4.379

3.  Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine.

Authors:  Christian Ruiz; Stefan Kustermann; Elina Pietilae; Tatjana Vlajnic; Betty Baschiera; Leila Arabi; Thomas Lorber; Martin Oeggerli; Spasenija Savic; Ellen Obermann; Thomas Singer; Sacha I Rothschild; Alfred Zippelius; Adrian B Roth; Lukas Bubendorf
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

4.  Diagnostic value of D2-40 immunostaining for malignant mesothelioma: a meta-analysis.

Authors:  Chao He; Bo Wang; Chun Wan; Ting Yang; Yongchun Shen
Journal:  Oncotarget       Date:  2017-07-06

5.  The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion.

Authors:  Monireh Halimi; Samad BeheshtiRouy; Davood Salehi; Seyed Ziaeddin Rasihashemi
Journal:  Iran J Pathol       Date:  2019-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.